hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c0cc01166e | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!